Climedo

43 neue Medikamente in Deutschland zugelassen, davon 27 für seltene Erkrankungen – ein Fortschritt für Patient:innen! Auch RSV-Impfstoffe & Reserveantibiotika dabei. Trotzdem bleibt Handlungsbedarf bei Antibiotika-Resistenzen. Mehr im @Dt_Aerzteblatt: eu1.hubs.ly/H0fTc1C0

Missed our Climedo Connect on DTx back in September? Now’s your chance to catch up! 🎥 Watch the webinar on demand now eu1.hubs.ly/H0fwwJn0 #DigitalTherapeutics #DTx #HealthcareInnovation #ClimedoConnect

Revolutionizing Clinical Trials with Digital Twins. With the market for digital twins in clinical trials projected to grow from $1.17 billion in 2022 to $38.43 billion by 2032, this technology is set to accelerate breakthroughs in personalized medicine. eu1.hubs.ly/H0fwwkk0

Missed our #ClimedoConnect webinar back in Oct? Watch the on-demand session to explore how combining Patient Centricity with Real-World Evidence (RWE) is transforming healthcare: eu1.hubs.ly/H0ftRFk0

🌟 Early cineole use can significantly reduce common cold symptoms & recovery time. 📉 Patients treated within 12h saw a 38% lower symptom burden. Data captured seamlessly via Climedo's eDiary ensured real-time, accurate insights. eu1.hubs.ly/H0ftR330

Unstructured data in #RWE studies is no longer a challenge—thanks to #GenAI! 🌟 Discover how GenAI is transforming clinical notes, patient feedback & more into actionable insights. Faster, smarter, better healthcare outcomes await. 🧠 Learn more: eu1.hubs.ly/H0ftRDV0

Breaking Barriers to Access in Oncology 📊 Faster decisions in some EU markets ⏳ Delays persist for combo therapies in others 🔬 RWE & mature data key to success IQVIA's ISPOR EU 2024 study reveals trends in patient access to innovation across UK & EU. eu1.hubs.ly/H0ftPpj0

This International Women’s Day 2025, we’re stepping forward in solidarity to help #AccelerateAction for gender equality. Join us on March 8 and take decisive steps to accelerate the momentum for change. 🌍💜

Why KOL Engagement Matters in Phase IV Trials 💡 Build trust through open dialogue 📊 Share real-time data via dashboards 🔬 Involve KOLs in cutting-edge discoveries Engage effectively to boost credibility, data collection and patient access to treatments eu1.hubs.ly/H0ftR1G0

This #RareDiseaseDay, Climedo supports innovative treatments for rare diseases with cutting-edge clinical trial solutions. Let’s unite for the 300M people living with rare diseases and advocate for equity in healthcare and diagnosis. 💙💚💜 #ClinicalTrials #EquityForRareDiseases

Just 1 week to go before we discuss omnichannel innovation for rare disease Medical Affairs in our #ClimedoConnect with @novonordisk – join us on February 26 to talk about crafting omnichannel strategies for rare disease medical affairs: eu1.hubs.ly/H0fvY8Y0

Getting Drugs to Patients Faster. Colleen Dixon: Pharma 4.0 + AI = streamlined processes & faster tech transfer 🚀 Mary Lou Glotzbach: Patient-centric delivery + sustainability 🌍 Learn more via @medicine_maker eu1.hubs.ly/H0ftC8y0

In case you missed one of our top blog posts last year on our trial physician survey results – here's a quick recap. 🔍 eu1.hubs.ly/H0fRdD70

Eine Umfrage zeigt: 2/3 der Ärzte sehen KI als Schlüssel für bessere Versorgung und Entlastung. Doch es besteht großer Weiterbildungsbedarf – gerade bei Haftungsfragen und Kontrollverlust. Mehr dazu im @Dt_Aerzteblatt: eu1.hubs.ly/H0ftBqs0

Ready to take your HCP engagement to the next level? Join us on February 26, 2025, at 3 PM CET for an exclusive webinar: "Connecting the Dots: Omnichannel Engagement in Rare Disease Medical Affairs." eu1.hubs.ly/H0fvYqr0

It's #WorldCancerDay. 💙 Join us this February 4 as we stand together for a future where cancer care is about more than just treatment—it’s about people.

Generative AI could cut costs, save time, & increase equity in clinical trials. 5 possibilities: 1️⃣ Faster trial design 2️⃣ Smarter site selection 3️⃣ Diverse patient recruitment 4️⃣ Automated data analysis 5️⃣ Streamlined regulatory submission eu1.hubs.ly/H0fn_bh0

In her guest blog post, Patient Expert Clarinda Cerejo describes the meaning of empathy in a clinical context, why it is missing in clinical interactions and whether empathy can be taught. She also looks at the role of AI. Read her full blog post here: eu1.hubs.ly/H0ftBZM0

💡 Building Responsible AI in Healthcare 💡 A new case study from the Mass General Brigham AI Governance Committee offers a blueprint for integrating artificial intelligence (AI) into healthcare responsibly. eu1.hubs.ly/H0f79Ct0

How can medical affairs teams meet HCPs’ rising expectations for connected communication while optimizing ROI? The answer lies in omnichannel engagement. Don’t miss our upcoming webinar on February 26: eu1.hubs.ly/H0fvXC00